statistiche ricercatore

NOONAN, DOUGLAS

Distribuzione geografica

Continente	#
NA - Nord America	23.919
EU - Europa	13.261
AS - Asia	7.877
SA - Sud America	983
AF - Africa	165
Continente sconosciuto - Info sul continente non disponibili	41
OC - Oceania	21
AN - Antartide	1
Totale	46.268

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	23.648
IT - Italia	6.740
SG - Singapore	2.647
UA - Ucraina	1.987
CN - Cina	1.642
VN - Vietnam	1.210
TR - Turchia	926
HK - Hong Kong	863
SE - Svezia	854
BR - Brasile	802
DE - Germania	760
FI - Finlandia	600
IE - Irlanda	596
GB - Regno Unito	546
FR - Francia	481
RU - Federazione Russa	303
IN - India	124
MX - Messico	117
BD - Bangladesh	116
CA - Canada	116
JP - Giappone	101
NL - Olanda	66
NG - Nigeria	64
AR - Argentina	63
ES - Italia	59
PL - Polonia	53
IQ - Iraq	40
ZA - Sudafrica	40
AT - Austria	39
BE - Belgio	38
EU - Europa	35
ID - Indonesia	33
EC - Ecuador	30
CZ - Repubblica Ceca	22
CO - Colombia	20
UZ - Uzbekistan	19
LT - Lituania	18
AE - Emirati Arabi Uniti	17
PK - Pakistan	17
PY - Paraguay	17
SA - Arabia Saudita	17
VE - Venezuela	17
MA - Marocco	16
AU - Australia	15
CH - Svizzera	15
CL - Cile	14
JO - Giordania	12
PH - Filippine	12
CR - Costa Rica	11
TH - Thailandia	11
KE - Kenya	10
PT - Portogallo	10
TN - Tunisia	10
MD - Moldavia	9
NP - Nepal	9
PE - Perù	9
EG - Egitto	8
KZ - Kazakistan	8
UY - Uruguay	8
LU - Lussemburgo	7
RO - Romania	7
DZ - Algeria	6
GR - Grecia	6
HN - Honduras	6
LB - Libano	6
MY - Malesia	6
NZ - Nuova Zelanda	6
AL - Albania	5
AZ - Azerbaigian	5
DK - Danimarca	5
HU - Ungheria	5
IL - Israele	5
KR - Corea	5
NO - Norvegia	5
TT - Trinidad e Tobago	5
A2 - ???statistics.table.value.countryCode.A2???	4
KG - Kirghizistan	4
PA - Panama	4
QA - Qatar	4
BA - Bosnia-Erzegovina	3
BG - Bulgaria	3
BN - Brunei Darussalam	3
BY - Bielorussia	3
DO - Repubblica Dominicana	3
HR - Croazia	3
JM - Giamaica	3
RS - Serbia	3
TW - Taiwan	3
AO - Angola	2
BB - Barbados	2
BH - Bahrain	2
BO - Bolivia	2
CG - Congo	2
LI - Liechtenstein	2
LV - Lettonia	2
NI - Nicaragua	2
OM - Oman	2
PS - Palestinian Territory	2
XK - ???statistics.table.value.countryCode.XK???	2
AD - Andorra	1
Totale	46.246

Salva come PNG Salva come JPEG

Città	#
Milan	4.580
Fairfield	2.685
Ashburn	1.954
San Jose	1.796
Woodbridge	1.790
Jacksonville	1.534
Singapore	1.415
Chandler	1.332
Houston	1.316
Seattle	1.105
Wilmington	975
Cambridge	920
Hong Kong	846
Ann Arbor	813
Dublin	594
Princeton	564
Dearborn	507
Dallas	477
Izmir	464
Nyköping	416
Boardman	390
Como	368
Beijing	365
Chicago	365
Rome	340
Dong Ket	334
The Dalles	324
Lauterbourg	271
Council Bluffs	252
Los Angeles	236
New York	219
Ho Chi Minh City	189
San Mateo	187
San Diego	177
Hanoi	121
Helsinki	117
London	109
Santa Clara	109
Munich	98
Ogden	88
Tokyo	87
Guangzhou	84
São Paulo	83
Buffalo	71
Orem	70
Abuja	63
Düsseldorf	62
Hefei	62
Mexico City	59
Nanjing	59
Washington	54
Kunming	53
Montreal	53
Brooklyn	50
Frankfurt am Main	47
Warsaw	45
Shanghai	44
Chennai	41
Manchester	41
Salt Lake City	41
Turku	39
Jinan	38
Phoenix	38
Varese	38
Norwalk	37
Stockholm	37
Verona	37
Brussels	35
Da Nang	34
Ponte Lambro	34
Poplar	31
Tianjin	30
Boston	29
Denver	29
Johannesburg	28
Nuremberg	28
San Francisco	28
Falls Church	27
Atlanta	26
Elk Grove Village	25
Kocaeli	25
Nanchang	24
Vienna	24
Amsterdam	22
Rio de Janeiro	22
Haiphong	21
Toronto	21
Columbus	20
Edinburgh	20
Magnago	20
Zhengzhou	20
Des Moines	19
Ankara	18
Baghdad	18
Berlin	18
Chengdu	18
Tashkent	18
Hangzhou	17
Brno	16
Rho	16
Totale	32.956

Salva come PNG Salva come JPEG

Nome	#
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer	325
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	307
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	300
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	282
Tumor inflammatory angiogenesis and its chemoprevention	281
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: Systemic distribution, macrophage accumulation, and amyloid deposition	265
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.	256
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity	250
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis	248
Strategies to Prevent "bad Luck" in Cancer	247
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	244
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	240
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	240
Unsung hero Robert C. Gallo	239
Biomarkers of cancer angioprevention for clinical studies	237
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection	235
Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells	231
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	231
A single cis-acting element in a short promoter segment of the gene encoding the interphotoreceptor retinoid-binding protein confers tissue- specific expression	226
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	226
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	224
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells	222
Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy	221
ANGIOGENIC POTENTIAL IN-VIVO BY KAPOSIS-SARCOMA CELL-FREE SUPERNATANTS AND HIV-1 TAT PRODUCT - INHIBITION OF KS-LIKE LESIONS BY TISSUE INHIBITOR OF METALLOPROTEINASE-2	220
Effect of a Purified Extract of Olive Mill Waste Water on Endothelial Cell Proliferation, Apoptosis, Migration and Capillary-Like Structure in vitro and in vivo.	220
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	220
Angiogenesis and cancer prevention: a vision	217
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues	216
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	216
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo	215
Net amyloidogenic backbone in human activated neutrophils	212
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	210
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes	210
Transgenic mice overexpressing arginase 1 in monocytic cell lineage are affected by lympho-myeloproliferative disorders and disseminated intravascular coagulation	208
SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses	208
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	208
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	207
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention	206
Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry	205
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	205
Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies.	202
Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors	201
Orchestration of angiogenesis by immune cells	201
Interactions of single-wall carbon nanotubes with endothelial cells.	200
Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells	200
N-(4-hydroxyphenyl) retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death	198
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo	198
Angiogenesis at the interface between basic and clinical research	194
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	194
Prediction of breast cancer metastasis by genomic profiling: where do we stand?	193
Fenretinide (4-HPR) targets caspase-9, ERK 1/2 and the Wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids	193
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	193
The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells	192
Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment	192
Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer	192
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth	191
SANIST: A rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers	191
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	191
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target.	188
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	188
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	188
Cancer prevention by targeting angiogenesis	187
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo	187
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	187
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	187
The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes	186
Paradoxic effects of metformin on endothelial cells and angiogenesis.	184
KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma	183
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	183
TREATMENT WITH A GLYCOSAMINOGLYCAN FORMULATION AMELIORATES EXPERIMENTAL DIABETIC NEPHROPATHY	182
Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA	181
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the flk-1/KDR (VEGFR-2): Relevance in AIDS-KS pathology	181
Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids	181
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	181
Neutrophils and angiogenesis: potential initiators of the angiogenic cascade	179
Anti-KS activity still a mystery	177
Multiple points of intervention in the prevention of cancer and other mutation-related diseases	177
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent	177
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells	177
RNASET2 as a tumor antagonizing gene in a melanoma cancer model	176
Surface activated chemical ionization - Electrospray mass spectrometry in the analysis of urinary thiodiglycolic acid	176
Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress	174
Biosynthesis and structure of the basement membrane proteoglycan containing heparan sulphate side-chains	174
Cytokine Loaded Biopolymers as a Novel Strategy to Study Stem Cells during Wound Healing Processes.	173
Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.	173
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells	173
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs	172
The Angiogenic Switch: Role of Immune Cells	172
LAMININ-INDUCED RETINOBLASTOMA CELL-DIFFERENTIATION - POSSIBLE INVOLVEMENT OF A 100-KDA CELL-SURFACE LAMININ-BINDING PROTEIN	171
MODULATION OF Y-79 RETINOBLASTOMA CELL-DIFFERENTIATION AND IRBP EXPRESSION BY DIBUTYRYL-CYCLIC-AMP AND LAMININ	171
Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis	171
PERLECAN, THE LARGE LOW-DENSITY PROTEOGLYCAN OF BASEMENT-MEMBRANES - STRUCTURE AND VARIANT FORMS	170
The leech: a novel invertebrate model for studying muscle regeneration and diseases	170
Kaposis sarcoma and human chorionic gonadotropin: Mechanisms, moieties and mysteries	169
Cannabidiol inhibits angiogenesis by multiple mechanisms	169
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein	168
Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation	168
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic eﬀectors	168
Proteoglycans of basement membranes	167
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.	167
Totale	20.329

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	182.874
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	182.874

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	646	0	0	0	0	0	0	0	0	0	0	0	646
2021/2022	2.898	413	267	227	95	99	143	193	140	218	449	260	394
2022/2023	3.695	379	190	296	394	257	810	10	494	512	119	126	108
2023/2024	7.192	1.093	1.129	1.128	1.269	1.386	394	40	172	146	124	15	296
2024/2025	4.408	76	53	852	119	130	250	162	295	505	446	427	1.093
2025/2026	10.626	673	546	600	1.458	999	553	2.416	655	1.100	775	493	358
Totale													46.583